Wolf ME - Search Results

1

Enhancement of human natural killer cell activity by opioid peptides: similar response to methionine-enkephalin and beta-endorphin.

Puente J, Maturana P, Miranda D, Navarro C, Wolf ME, Mosnaim AD. Puente J, et al. Among authors: wolf me. Brain Behav Immun. 1992 Mar;6(1):32-9. doi: 10.1016/0889-1591(92)90057-u. Brain Behav Immun. 1992. PMID: 1571602

2

Administration of butaperazine and plasma methionine-enkephalin levels in schizophrenic and affective disorder patients with tardive dyskinesia.

Mosnaim AD, Wolf ME. Mosnaim AD, et al. Among authors: wolf me. J Clin Psychopharmacol. 1988 Aug;8(4 Suppl):27S-30S. J Clin Psychopharmacol. 1988. PMID: 2906066

3

Enhancement of natural killer cell activity in septic shock patients by a mixture of the calcium ionophore A23187 and the phorbol ester TPA: in vitro studies.

Puente J, Carvajal T, Parra S, Miranda D, Sepulveda C, Wolf ME, Mosnaim AD. Puente J, et al. Among authors: wolf me. Int J Clin Pharmacol Ther. 1994 Jan;32(1):19-23. Int J Clin Pharmacol Ther. 1994. PMID: 8199746

4

In vitro studies of natural killer cell activity in septic shock patients. Response to a challenge with alpha-interferon and interleukin-2.

Puente J, Carvajal T, Parra S, Miranda D, Sepulveda C, Wolf ME, Mosnaim AD. Puente J, et al. Among authors: wolf me. Int J Clin Pharmacol Ther Toxicol. 1993 Jun;31(6):271-5. Int J Clin Pharmacol Ther Toxicol. 1993. PMID: 8335423

5

Studies of natural killer cell activity in a drug-free, healthy population. Response to a challenge with taxol, estramustine and lipopolysaccharide.

Puente J, Diaz M, Salas MA, Miranda D, Gaggero A, Wolf ME, Mosnaim AD. Puente J, et al. Among authors: wolf me. Int J Clin Pharmacol Ther. 1995 Aug;33(8):457-61. Int J Clin Pharmacol Ther. 1995. PMID: 8556226

6

Activation of protein tyrosine kinase: a possible requirement for fixed-bacteria and lipopolysaccharide-induced increase in human natural killer cell activity.

Puente J, Salas MA, Canon C, Miranda D, Wolf ME, Mosnaim AD. Puente J, et al. Among authors: wolf me. Int J Clin Pharmacol Ther. 1996 May;34(5):212-8. Int J Clin Pharmacol Ther. 1996. PMID: 8738858 Clinical Trial.

7

In vitro effect of bacterial lipopolysaccharide on the cytotoxicity of human natural killer cells.

Miranda D, Puente J, Blanco L, Wolf ME, Mosnaim AD. Miranda D, et al. Among authors: wolf me. Res Commun Mol Pathol Pharmacol. 1998 Apr;100(1):3-14. Res Commun Mol Pathol Pharmacol. 1998. PMID: 9644714

8

Enhancement of natural killer cell activity in HIV-1-infected subjects by a mixture of the calcium ionophore A23187 and the phorbol ester TPA: lack of response to a similar challenge with interleukin-2 or alpha-interferon.

Sepúlveda C, Puente J, Weinstein C, Wolf ME, Mosnaim AD. Sepúlveda C, et al. Among authors: wolf me. Am J Ther. 1997 Nov-Dec;4(11-12):413-21. doi: 10.1097/00045391-199711000-00013. Am J Ther. 1997. PMID: 10423640

9

Effect of Salmonella typhi wild type and O-antigen mutants on human natural killer cell activity.

Puente J, Blanco L, Montoya M, Miranda D, Contreras I, Vinés E, Wolf ME, Mosnaim AD. Puente J, et al. Among authors: wolf me. Int J Immunopharmacol. 2000 May;22(5):355-64. doi: 10.1016/s0192-0561(99)00089-2. Int J Immunopharmacol. 2000. PMID: 10708883

10

Effect of Salmonella-infected human monocytes on natural killer cell cytotoxicity. In vitro studies.

Blanco L, Puente J, Carrasco C, Miranda D, Wolf ME, Mosnaim AD. Blanco L, et al. Among authors: wolf me. Int Immunopharmacol. 2001 Jul;1(7):1285-93. doi: 10.1016/s1567-5769(01)00060-1. Int Immunopharmacol. 2001. PMID: 11460309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results